Literature DB >> 36111834

Identification and Utilization of a Chemical Probe to Interrogate the Roles of PIKfyve in the Lifecycle of β-Coronaviruses.

David H Drewry1,2, Frances M Potjewyd1, Armin Bayati3, Jeffery L Smith1, Rebekah J Dickmander2,4,5,6, Stefanie Howell1, Sharon Taft-Benz4,7, Sophia M Min1, Mohammad Anwar Hossain1, Mark Heise4,7, Peter S McPherson3, Nathaniel J Moorman2,4,5, Alison D Axtman1.   

Abstract

From a designed library of indolyl pyrimidinamines, we identified a highly potent and cell-active chemical probe (17) that inhibits phosphatidylinositol-3-phosphate 5-kinase (PIKfyve). Comprehensive evaluation of inhibitor selectivity confirmed that this PIKfyve probe demonstrates excellent kinome-wide selectivity. A structurally related indolyl pyrimidinamine (30) was characterized as a negative control that lacks PIKfyve inhibitory activity and exhibits exquisite selectivity when profiled broadly. Chemical probe 17 disrupts multiple phases of the lifecycle of β-coronaviruses: viral replication and viral entry. The diverse antiviral roles of PIKfyve have not been previously probed comprehensively in a single study or using the same compound set. Our scaffold is a distinct chemotype that lacks the canonical morpholine hinge-binder of classical lipid kinase inhibitors and has a non-overlapping kinase off-target profile with known PIKfyve inhibitors. Our chemical probe set can be used by the community to further characterize the role of PIKfyve in virology.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36111834      PMCID: PMC9574855          DOI: 10.1021/acs.jmedchem.2c00697

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   8.039


  50 in total

1.  Comprehensive analysis of kinase inhibitor selectivity.

Authors:  Mindy I Davis; Jeremy P Hunt; Sanna Herrgard; Pietro Ciceri; Lisa M Wodicka; Gabriel Pallares; Michael Hocker; Daniel K Treiber; Patrick P Zarrinkar
Journal:  Nat Biotechnol       Date:  2011-10-30       Impact factor: 54.908

2.  Discovery of Potent and Brain-Penetrant Tau Tubulin Kinase 1 (TTBK1) Inhibitors that Lower Tau Phosphorylation In Vivo.

Authors:  Tamara Halkina; Jaclyn L Henderson; Edward Y Lin; Martin K Himmelbauer; J Howard Jones; Marta Nevalainen; Jun Feng; Kristopher King; Michael Rooney; Joshua L Johnson; Douglas J Marcotte; Jayanth V Chodaparambil; P Rajesh Kumar; Thomas A Patterson; Paramasivam Murugan; Eli Schuman; LaiYee Wong; Thomas Hesson; Sarah Lamore; Channa Bao; Michael Calhoun; Hannah Certo; Brenda Amaral; Gregory M Dillon; Rab Gilfillan; Felix Gonzalez-Lopez de Turiso
Journal:  J Med Chem       Date:  2021-05-04       Impact factor: 7.446

3.  Brief report: a phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis.

Authors:  Sarah Krausz; Maria J H Boumans; Danielle M Gerlag; Joelle Lufkin; Arno W R van Kuijk; Alian Bakker; Maarten de Boer; Beatrijs M Lodde; Kris A Reedquist; Eric W Jacobson; Michael O'Meara; Paul P Tak
Journal:  Arthritis Rheum       Date:  2011-12-14

4.  Development of Three Orthogonal Assays Suitable for the Identification and Qualification of PIKfyve Inhibitors.

Authors:  Kylie Fogarty; Mohammed Kashem; Andras Bauer; Alexandra Bernardino; Debra Brennan; Brian Cook; Neil Farrow; Teresa Molinaro; Richard Nelson
Journal:  Assay Drug Dev Technol       Date:  2017-07       Impact factor: 1.738

5.  Insights into Lysosomal PI(3,5)P2 Homeostasis from a Structural-Biochemical Analysis of the PIKfyve Lipid Kinase Complex.

Authors:  Joshua A Lees; PeiQi Li; Nikit Kumar; Lois S Weisman; Karin M Reinisch
Journal:  Mol Cell       Date:  2020-10-23       Impact factor: 17.970

6.  Designing of kinase hinge binders: A medicinal chemistry perspective.

Authors:  Vikas Sharma; Mohit Gupta
Journal:  Chem Biol Drug Des       Date:  2022-02-03       Impact factor: 2.817

7.  Remdesivir for the Treatment of Covid-19 - Final Report.

Authors:  John H Beigel; Kay M Tomashek; Lori E Dodd; Aneesh K Mehta; Barry S Zingman; Andre C Kalil; Elizabeth Hohmann; Helen Y Chu; Annie Luetkemeyer; Susan Kline; Diego Lopez de Castilla; Robert W Finberg; Kerry Dierberg; Victor Tapson; Lanny Hsieh; Thomas F Patterson; Roger Paredes; Daniel A Sweeney; William R Short; Giota Touloumi; David Chien Lye; Norio Ohmagari; Myoung-Don Oh; Guillermo M Ruiz-Palacios; Thomas Benfield; Gerd Fätkenheuer; Mark G Kortepeter; Robert L Atmar; C Buddy Creech; Jens Lundgren; Abdel G Babiker; Sarah Pett; James D Neaton; Timothy H Burgess; Tyler Bonnett; Michelle Green; Mat Makowski; Anu Osinusi; Seema Nayak; H Clifford Lane
Journal:  N Engl J Med       Date:  2020-10-08       Impact factor: 91.245

8.  Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses.

Authors:  Xuan Yang; Rebekah J Dickmander; Armin Bayati; Sharon A Taft-Benz; Jeffery L Smith; Carrow I Wells; Emily A Madden; Jason W Brown; Erik M Lenarcic; Boyd L Yount; Edcon Chang; Alison D Axtman; Ralph S Baric; Mark T Heise; Peter S McPherson; Nathaniel J Moorman; Timothy M Willson
Journal:  ACS Chem Biol       Date:  2022-06-19       Impact factor: 4.634

Review 9.  Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2.

Authors:  Robert W Körner; Mohamed Majjouti; Miguel A Alejandre Alcazar; Esther Mahabir
Journal:  Viruses       Date:  2020-08-12       Impact factor: 5.048

10.  Identification of PIKfyve kinase as a target in multiple myeloma.

Authors:  Cecilia Bonolo de Campos; Yuan Xiao Zhu; Nikolai Sepetov; Sergei Romanov; Laura Ann Bruins; Chang-Xin Shi; Caleb K Stein; Joachim L Petit; Alysia N Polito; Meaghen E Sharik; Erin W Meermeier; Gregory J Ahmann; Ilsel D Lopez Armenta; Jonas Kruse; P Leif Bergsagel; Marta Chesi; Nathalie Meurice; Esteban Braggio; A Keith Stewart
Journal:  Haematologica       Date:  2019-10-03       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.